Posterior Reversible Encephalopathy Syndrome in the Critically Ill Patients

Last updated: August 7, 2019
Sponsor: Ictal Group
Overall Status: Active - Recruiting

Phase

N/A

Condition

Neurologic Disorders

Treatment

N/A

Clinical Study ID

NCT03470467
ICTAL PRES REGISTRY
  • Ages > 18
  • All Genders
  • Accepts Healthy Volunteers

Study Summary

Posterior Reversible Encephalopathy Syndrome prospective (PRES) registry. Data collection using a standardized form : demographic data and data related to the PRES, including circumstances of onset, dates and times of onset and of symptoms control, on-scene clinical findings, clinical and radiological features of PRES, pre-hospital and hospital care providers, timing of antiepileptic, antihypertensive drugs and supportive treatments, results of etiological investigations, cause of PRES, type and dosage of antiepileptic and antihypertensive drugs. Dates and times of EEG monitoring, EEG results, radiological and biological investigations. Outcomes including vital status and Glasgow Outcome Scale score at ICU and hospital discharge, day-90 and 1-year after SE and determined based on data in the ICU and/or neurologist charts and/or patients phone interview

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • age >= 18 years

  • Posterior Reversible Encephalopathy Syndrome defined as:

  • combination of consciousness impairment, seizure activity, headaches, visualabnormalities, nausea/vomiting, and focal neurological signs AND

  • cerebral imaging abnormalities involving the white matter (brain CT scanhypodensities AND/OR Brain MRI hypoT1, hyper T2 FLAIR)

  • intensive care unit admission

Exclusion

Exclusion Criteria:

  • normal cerebral imaging

Study Design

Total Participants: 300
Study Start date:
March 09, 2018
Estimated Completion Date:
December 31, 2028

Connect with a study center

  • Intensive Care Unit - Versailles Hospital

    Le Chesnay, 78150
    France

    Active - Recruiting

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.